(Q34148593)

31 July 2017

1 reference

title

Immunopathogenesis of hepatitis C virus in the immunosuppressed host (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

Einav S

1

1 reference

PubMed ID

12220245

31 July 2017

Koziel MJ

series ordinal

2

1 reference

31 July 2017

1 June 2002

1 reference

Transplant Infectious Disease

31 July 2017

1 reference

31 July 2017

4

1 reference

31 July 2017

2

1 reference

31 July 2017

85-92

1 reference

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

31 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Cytotoxic T lymphocytes, chemokines and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C virus: molecular biology and genetic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

A longitudinal analysis of hepatitis C virus replication following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Transgenic expression of hepatitis C virus structural proteins in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Cytokines in the generation of immune responses to, and resolution of, virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Lymphocyte subsets in renal allograft recipients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

Rising incidence of hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Immune escape in hepatocellular cancer: is a good offense the best defense?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Killing mechanisms of cytotoxic lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.2002.T01-2-02001.X

7 January 2021

10.1034/J.1399-3062.2002.T01-2-02001.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12220245